<DOC>
	<DOCNO>NCT01325090</DOCNO>
	<brief_summary>Botulinum toxin type A report inhibit release various pain neurotransmitter ( SP , CGRP , glutamate ) responsible neurogenic inflammation , process result sensitization C-fiber nociceptors ( peripheral sensitization ) . This action probably responsible analgesic effect botulinum toxin type A recently demonstrate patient neuropathic pain peripheral origin.In study , patient suffer year . The investigator hypothesize early administration Botox course neuropathic pain might prevent central sensitization , secondary peripheral sensitization . The investigator hope increase efficacy Botulinum toxin type A injection prevent chronification pain .</brief_summary>
	<brief_title>Early Administration BotoxÂ® Neuropathic Pain Due Thoracoscopy Thoracotomy</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>daily pain , 3 month , secondary thoracoscopy thoracotomy , neuropathic origin ( DN4 questionary ) contraindication botulinum toxin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>neuropathic pain due thoracotomy</keyword>
	<keyword>Neuropathic Pain Due Thoracoscopy</keyword>
</DOC>